Sitemap Downloadcenter Index Stock Market Dictionary

Fulltext search start Divisions 2003 (in € million) cosmed medical tesa Group Net sales 3,136 841 696 4,673 Change in % (nominal) -1.0 % -4.6 % +0.4 % -1.5 % Change in % (adjusted for currency translation effects) +4.1 % +2.0 % +5.7 % +4.0 % Share of Group sales 67.1 % 18.0 % 14.9 % 100.0 % EBITDA 490 96 62 648 Operating result (EBIT) 404 45 35 484 (as % of sales) 12.9 % 5.4 % 5.0 % 10.4 % Gross operating capital 1,505 464 467 2,436 Operating liabilities 593 138 111 842 EBIT return on capital employed 44.3 % 13.9 % 9.8 % 30.4 % Gross cash flow 285 71 45 401 Capital expenditure (excl. financial assets) 113 24 30 167 Depreciation (excl. financial assets) 86 51 27 164 Research and development expenses 60 26 14 100 Employees (as of Dec. 31, 2003) 9,625 5,033 3,591 18,249 Download Chart (MS Excel) Divisions 2002 (in € million) cosmed medical tesa Group Net sales 3,167 882 693 4,742 Change in % (nominal) +7.2 % -3.6 % +3.0 % +4.4 % Change in % (adjusted for currency translation effects) +10.3 % -0.8 % +4.9 % +7.3 % Share of Group sales 66.8 % 18.6 % 14.6 % 100.0 % EBITDA 493 87 53 633 Operating result (EBIT) 411 35 26 472 (as % of sales) 13.0 % 3.9 % 3.8 % 9.9 % Gross operating capital 1,456 535 486 2,477 Operating liabilities 558 139 117 814 EBIT return on capital employed 45.8 % 8.7 % 7.2 % 28.4 % Gross cash flow 323 71 47 441 Capital expenditure (excl. financial assets) 157 41 29 227 Depreciation (excl. financial assets) 82 52 27 161 Research and development expenses 55 24 14 93 Employees (as of Dec. 31, 2002) 9,380 5,133 3,670 18,183 Download Chart (MS Excel) Regions 2003 (in € million) Germany Europe excl. Germany Americas Africa/ Asia/ Australia Group Net sales *) 1,268 2,207 692 506 4,673 Change in % (nominal) -1.4 % +3.9 % -15.6 % -1.3 % -1.5 % Change in % (adjusted for currency translation effects) -1.4 % +6.8 % +2.0 % +8.5 % +4.0 % Share of Group sales 27.1 % 47.3 % 14.8 % 10.8 % 100.0 % EBITDA 258 298 37 55 648 Operating result (EBIT) 164 250 23 47 484 (as % of sales) 13.0 % 11.3 % 3.3 % 9.2 % 10.4 % Gross operating capital 858 1,055 327 196 2,436 Operating liabilities 355 343 71 73 842 EBIT return on capital employed 32.7 % 35.1 % 8.8 % 38.0 % 30.4 % Gross cash flow 121 216 26 38 401 Capital expenditure (excl. financial assets) 85 55 17 10 167 Depreciation (excl. financial assets) 93 48 14 9 164 Employees (as of Dec. 31, 2003) 6,724 5,728 2,765 3,032 18,249 *) based on companies’ domicile Download Chart (MS Excel) Regions 2002 (in € million) Germany Europe excl. Germany Americas Africa/ Asia/ Australia Group Net sales *) 1,286 2,124 819 513 4,742 Change in % (nominal) +2.4 % +10.3 % -9.3 % +12.3 % +4.4 % Change in % (adjusted for currency translation effects) +2.4 % +11.0 % +0.3 % +18.8 % +7.3 % Share of Group sales 27.1 % 44.8 % 17.3 % 10.8 % 100.0 % EBITDA 230 290 55 58 633 Operating result (EBIT) 141 243 39 49 472 (as % of sales) 11.0 % 11.4 % 4.8 % 9.4 % 9.9 % Gross operating capital 888 1,025 368 196 2,477 Operating liabilities 340 316 78 80 814 EBIT return on capital employed 25.8 % 34.2 % 13.6 % 41.8 % 28.4 % Gross cash flow 142 208 48 43 441 Capital expenditure (excl. financial assets) 124 65 28 10 227 Depreciation (excl. financial assets) 89 47 16 9 161 Employees (as of Dec. 31, 2002) 6,708 5,662 2,852 2,961 18,183 *) based on companies’ domicile Download Chart (MS Excel)

Top Download this chapter (PDF) Printable Version (PDF) e-mail this page